Alphatec Holdings’ Strategic Advancements and Valence Robotic Navigation System: A Buy Recommendation

Josh Jennings, an analyst from TD Cowen, reiterated the Buy rating on Alphatec Holdings. The associated price target remains the same with $22.50.

Josh Jennings has given his Buy rating due to a combination of factors that highlight Alphatec Holdings’ strategic advancements in their technology portfolio. By late 2025, the company is expected to fill the remaining gap in its offerings with the commercialization of the Valence robotic navigation system. This system is designed to enhance ATEC’s market share in the spine sector with its compact design and intuitive workflows, which are expected to accelerate adoption among surgeons.
Valence is not just another tool but a significant innovation within ATEC’s procedural ecosystem. It integrates seamlessly into existing workflows, particularly in posterior spine approaches, and is engineered to improve precision in implant placement. The system’s design focuses on scalability and workflow integration, distinguishing it from traditional, standalone robotic systems. This strategic move positions ATEC to democratize complex spine procedures, making them more accessible to surgeons and potentially increasing the company’s market penetration.